Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present CASI Pharmaceuticals, Inc. (NASDAQ: CASI).

Full DD Report for CASI

You must become a subscriber to view this report.


Recent News from (NASDAQ: CASI)

CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results
ROCKVILLE, Md. , May 15, 2018 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and thro...
Source: PR Newswire
Date: May, 15 2018 07:00
Detailed Research: Economic Perspectives on CASI Pharmaceuticals, Energy Transfer Partners, Cypress Semiconductor, Xcel Energy, Ironwood Pharmaceuticals, and KalVista Pharmaceuticals - What Drives Growth in Today's Competitive Landscape
NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CASI Pharmaceuticals, Inc. (NASDAQ:CASI), Energy Transfer Partners, L.P. (...
Source: GlobeNewswire
Date: May, 07 2018 07:30
Blog Exposure - Enanta Pharma Announced Presentation of New Data for Core Inhibitor for Hepatitis B Virus and FXR Agonist EDP-305 for NASH
Stock Monitor: CASI Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 16, 2018 / Active-Investors.com has just released a free research report on Enanta Pharma, Inc. (NASDAQ: ENTA ) ("Enanta"). If you want access to this report all you need to do is sign up now by clic...
Source: ACCESSWIRE IA
Date: April, 16 2018 07:40
Midday Gainers / Losers (04/06/2018)
Gainers: NVCN +56% . LFIN +47% . OGEN +29% . BWEN +25% . CASI +16% . FORD +14% . MBII +10% . ABIL +10% . GEN +10% . TNTR +9% . More news on: Neovasc Inc., LongFin Corp, Oragenics, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 06 2018 12:36
CASI Pharmaceuticals Provides Update On EVOMELA®
ROCKVILLE, Md. , April 5, 2018 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces receipt of a letter from the Ce...
Source: PR Newswire
Date: April, 05 2018 08:00
Premarket Gainers as of 9:05 am (04/04/2018)
ASTC +23%  as its new explosives trace detector, the TRACER 1000, has entered into Developmental Test and Evaluation at the U.S. Department of Homeland Security Transportation Security Laboratory. More news on: Astrotech Corporation, Tenax Therapeutics, Inc., CASI Pharmaceu...
Source: SeekingAlpha
Date: April, 04 2018 09:17
Midday Gainers / Losers (4/3/2018)
Gainers: MYND +66% . BPTH +33% . EBIO +23% . INNT +22% . ALNA +19% . CASI +19% . SSC +18% . URGN +18% . CLLS +17% . REFR +13% . More news on: MYnd Analytics, Inc., Bio-Path Holdings, Inc., Eleven Biotherapeutics, Inc., Stocks on the move, , Read more .....
Source: SeekingAlpha
Date: April, 03 2018 12:45
CASI Pharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Conference
ROCKVILLE, Md. , April 3, 2018 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces it will present at the H.C. Wai...
Source: PR Newswire
Date: April, 03 2018 07:00
Midday Gainers / Losers (4/2/2018)
Gainers: SLS +167% . SSC +23% . MNOV +21% . ALNA +18% . MARK +15% . BLFS +15% . MBII +14% . CASI +12% . TCON +12% . CHCI +12% . More news on: SELLAS Life Sciences Group, Inc., Seven Stars Cloud Group, Inc., MediciNova, Inc., Stocks on the move, , Read m...
Source: SeekingAlpha
Date: April, 02 2018 12:45
CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results
ROCKVILLE, Md. , March 29, 2018 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, today reported financial results for the...
Source: PR Newswire
Date: March, 29 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-167.597.3957.757.35183,272
2018-08-157.327.597.847.32216,643
2018-08-148.167.868.307.20345,335
2018-08-138.008.11248.89167.921,043,848
2018-08-107.357.97028.197.35655,316

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1614,41841,11335.0692Short
2018-08-1516,67240,06841.6093Short
2018-08-1437,901121,36031.2302Cover
2018-08-13187,655391,94747.8776Short
2018-08-1094,312144,83665.1164Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CASI.


About CASI Pharmaceuticals, Inc. (NASDAQ: CASI)

Logo for CASI Pharmaceuticals, Inc. (NASDAQ: CASI)

Not available

 

Contact Information

 

 

Current Management

  • Ken Ren / CEO
  • Sara Capitelli / CFO
  • Cynthia Wu / General Counsel

Current Share Structure

  • Market Cap: $625,985,145 - 05/14/2018
  • Issue and Outstanding: 79,641,876 - 03/28/2018

 


Recent Filings from (NASDAQ: CASI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 14 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 23 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 17 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 23 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: March, 20 2018

 

 


Daily Technical Chart for (NASDAQ: CASI)

Daily Technical Chart for (NASDAQ: CASI)


Stay tuned for daily updates and more on (NASDAQ: CASI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CASI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CASI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CASI and does not buy, sell, or trade any shares of CASI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/